Shopping Cart
Remove All
Your shopping cart is currently empty
EG-011 is a first-in-class and potent activator of Wiskott-Aldrich syndrome protein (WASP) that relieves autoinhibition of WASP and robustly induces actin polymerization, EG-011 exhibits selective antitumor activity in lymphomas, supporting its use in cancer biology research to investigate cytoskeletal regulation, immune cell signaling, and WASP-driven tumor vulnerabilities.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $764 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $1,190 | 8-10 weeks | 8-10 weeks |
| Description | EG-011 is a first-in-class and potent activator of Wiskott-Aldrich syndrome protein (WASP) that relieves autoinhibition of WASP and robustly induces actin polymerization, EG-011 exhibits selective antitumor activity in lymphomas, supporting its use in cancer biology research to investigate cytoskeletal regulation, immune cell signaling, and WASP-driven tumor vulnerabilities. |
| In vitro | In lymphoma cell lines (OCI-LY-19, REC1), EG-011 induced dose-dependent cell death (20-55%) at concentrations of 500 nM to 2 μM over 72 hours. Treatment (500 nM-5 μM) triggered actin polymerization in sensitive cells within 4-24 hours, while showing no cytotoxicity towards normal PBMCs even at high concentrations (1-10 mM) [1]. |
| In vivo | In female NOD-SCID mice bearing Mantle Cell Lymphoma (MCL REC-1) xenografts, intraperitoneal (i.p.) administration of EG-011 (200 mg/kg, 5 days per week) delayed tumor progression. At the conclusion of the study, tumor volume in the treated group was 2.2-fold smaller than that of the control group (P < 0.001), without observations of systemic toxicity [1]. |
| Synonyms | EG011, EG 011 |
| Molecular Weight | 482.53 |
| Formula | C28H26N4O4 |
| Cas No. | 2377113-41-0 |
| Smiles | O=C(C=C)N1CCCC(N2C(=O)C3=NC=CC=C3N(C2=O)CC4=CC=C(OC=5C=CC=CC5)C=C4)C1 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (207.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.